As of 2025-07-18, the Intrinsic Value of Sensei Biotherapeutics Inc (SNSE) is -104.13 USD. This SNSE valuation is based on the model Peter Lynch Fair Value. With the current market price of 8.02 USD, the upside of Sensei Biotherapeutics Inc is -1,398.40%.
Based on its market price of 8.02 USD and our intrinsic valuation, Sensei Biotherapeutics Inc (SNSE) is overvalued by 1,398.40%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -104.13 - -104.13 | -104.13 | -1,398.40% |
| P/E | (364.46) - (504.83) | (450.89) | -5722.1% |
| DDM - Stable | (197.25) - (629.07) | (413.16) | -5251.6% |
| DDM - Multi | (185.54) - (465.21) | (265.89) | -3415.4% |
| Market Cap (mil) | 11.18 |
| Beta | 2.15 |
| Outstanding shares (mil) | 1.39 |
| Enterprise Value (mil) | 1.92 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.19% |
| Cost of Debt | 5.00% |
| WACC | 8.81% |